rs17082236

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.24502G>T​(p.Ala8168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0602 in 1,613,862 control chromosomes in the GnomAD database, including 5,404 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A8168D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.12 ( 1995 hom., cov: 32)
Exomes 𝑓: 0.054 ( 3409 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.57
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0038188696).
BP6
Variant 6-152149617-C-A is Benign according to our data. Variant chr6-152149617-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 130426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152149617-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.24502G>T p.Ala8168Ser missense_variant 136/146 ENST00000367255.10
SYNE1NM_001347702.2 linkuse as main transcriptc.967G>T p.Ala323Ser missense_variant 7/18 ENST00000354674.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.24502G>T p.Ala8168Ser missense_variant 136/1461 NM_182961.4 P1Q8NF91-1
SYNE1ENST00000354674.5 linkuse as main transcriptc.967G>T p.Ala323Ser missense_variant 7/185 NM_001347702.2

Frequencies

GnomAD3 genomes
AF:
0.119
AC:
18087
AN:
151924
Hom.:
1993
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.290
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0937
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.0278
Gnomad FIN
AF:
0.0404
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.0495
Gnomad OTH
AF:
0.127
GnomAD3 exomes
AF:
0.0646
AC:
16253
AN:
251452
Hom.:
1122
AF XY:
0.0597
AC XY:
8115
AN XY:
135902
show subpopulations
Gnomad AFR exome
AF:
0.298
Gnomad AMR exome
AF:
0.0560
Gnomad ASJ exome
AF:
0.108
Gnomad EAS exome
AF:
0.000544
Gnomad SAS exome
AF:
0.0293
Gnomad FIN exome
AF:
0.0420
Gnomad NFE exome
AF:
0.0541
Gnomad OTH exome
AF:
0.0681
GnomAD4 exome
AF:
0.0540
AC:
79004
AN:
1461820
Hom.:
3409
Cov.:
32
AF XY:
0.0528
AC XY:
38363
AN XY:
727214
show subpopulations
Gnomad4 AFR exome
AF:
0.292
Gnomad4 AMR exome
AF:
0.0592
Gnomad4 ASJ exome
AF:
0.112
Gnomad4 EAS exome
AF:
0.000252
Gnomad4 SAS exome
AF:
0.0291
Gnomad4 FIN exome
AF:
0.0426
Gnomad4 NFE exome
AF:
0.0486
Gnomad4 OTH exome
AF:
0.0699
GnomAD4 genome
AF:
0.119
AC:
18115
AN:
152042
Hom.:
1995
Cov.:
32
AF XY:
0.117
AC XY:
8691
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.290
Gnomad4 AMR
AF:
0.0933
Gnomad4 ASJ
AF:
0.117
Gnomad4 EAS
AF:
0.000580
Gnomad4 SAS
AF:
0.0278
Gnomad4 FIN
AF:
0.0404
Gnomad4 NFE
AF:
0.0495
Gnomad4 OTH
AF:
0.126
Alfa
AF:
0.0690
Hom.:
1229
Bravo
AF:
0.132
TwinsUK
AF:
0.0442
AC:
164
ALSPAC
AF:
0.0459
AC:
177
ESP6500AA
AF:
0.286
AC:
1259
ESP6500EA
AF:
0.0548
AC:
471
ExAC
AF:
0.0678
AC:
8226
Asia WGS
AF:
0.0220
AC:
78
AN:
3478
EpiCase
AF:
0.0579
EpiControl
AF:
0.0630

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxJan 28, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 02, 2018- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;.;.;T;T;T;T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.30
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.74
T;T;T;T;T;T;T
MetaRNN
Benign
0.0038
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.;.;.;.;.;.
MutationTaster
Benign
0.99
P;P;P;P;P;P;P;P
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.7
N;N;N;N;N;N;N
REVEL
Benign
0.041
Sift
Benign
0.43
T;T;T;T;T;T;T
Sift4G
Benign
0.43
T;T;T;T;T;T;T
Polyphen
0.0010
B;.;.;.;.;.;.
Vest4
0.16
MPC
0.12
ClinPred
0.011
T
GERP RS
4.0
Varity_R
0.15
gMVP
0.11

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17082236; hg19: chr6-152470752; COSMIC: COSV54938531; COSMIC: COSV54938531; API